Inge M. van der Sluis, M.D., Ph.D., Paola de Lorenzo, Ph.D.,Rishi S. Kotecha, M.B., Ch.B., Ph.D.,. Blinatumomab added to upfront chemotherapy in infant lymphoblastic leukemia. NEJM. 2023, 388 (17): 1572–1581. PMID 37099340.
Angus Hodder, MBBS1 ; Avijeet K. Mishra, MBBS1 ; Amir Enshaei, PhD2; Susan Baird, MD3; Ismail Elbeshlawi, FRCPath4 ; Denise Bonney, PhD. Blinatumomab for First-Line Treatment of Children and Young Persons With B-ALL. JCO. 2024, 42 (8). PMID 37967307.